Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hannah, Garner"'
Autor:
Sarah Roberts-Lewis, Helen Baxter, Gill Mein, Sophia Quirke-McFarlane, Fiona J Leggat, Hannah Garner, Martha Powell, Sarah White, Lindsay Bearne
Publikováno v:
Journal of Medical Internet Research, Vol 26, p e51418 (2024)
BackgroundSocial media use has potential to facilitate the rapid dissemination of research evidence to busy health and social care practitioners. ObjectiveThis study aims to quantitatively synthesize evidence of the between- and within-group effecti
Externí odkaz:
https://doaj.org/article/3187318239dd4203a4a63534f417e1af
Autor:
Olga S. Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I. Isaeva, Hannah Garner, Max D. Wellenstein, Noor Bakker, Danique E.M. Duits, Kelly Kersten, Sjoerd Klarenbeek, Cheei-Sing Hau, Daphne Kaldenbach, Elisabeth A.M. Raeven, Kim Vrijland, Marleen Kok, Karin E. de Visser
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTThe clinical successes of immune checkpoint blockade (ICB) in advanced cancer patients have recently spurred the clinical implementation of ICB in the neoadjuvant and perioperative setting. However, how neoadjuvant ICB therapy affects the sys
Externí odkaz:
https://doaj.org/article/b656e036ddb5458b8a3bb50ca339a61b
Autor:
Leonie Voorwerk, Olga I. Isaeva, Hugo M. Horlings, Sara Balduzzi, Maksim Chelushkin, Noor A. M. Bakker, Elisa Champanhet, Hannah Garner, Karolina Sikorska, Claudette E. Loo, Inge Kemper, Ingrid A. M. Mandjes, Michiel de Maaker, Jasper J. L. van Geel, Jorianne Boers, Maaike de Boer, Roberto Salgado, Marloes G. J. van Dongen, Gabe S. Sonke, Karin E. de Visser, Ton N. Schumacher, Christian U. Blank, Lodewyk F. A. Wessels, Agnes Jager, Vivianne C. G. Tjan-Heijnen, Carolien P. Schröder, Sabine C. Linn, Marleen Kok
Publikováno v:
Nature Cancer, 4, 535-549. Springer Nature
Nature Cancer, 4(4), 535-549. Nature Research
Nature Cancer, 4(4), 535-549. Nature Research
Invasive lobular breast cancer (ILC) is the second most common histological breast cancer subtype, but ILC-specific trials are lacking. Translational research revealed an immune-related ILC subset, and in mouse ILC models, synergy between immune chec
Autor:
Calum C. Bain, Catherine A. Hawley, Hannah Garner, Charlotte L. Scott, Anika Schridde, Nicholas J. Steers, Matthias Mack, Anagha Joshi, Martin Guilliams, Allan Mc I. Mowat, Frederic Geissmann, Stephen J. Jenkins
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
Understanding the heterogeneity of peritoneal macrophages is hampered by controversy over their origin and homeostasis. Here the authors show the embryonic F4/80hi population is replaced over time by self-renewing bone marrow-derived cells transition
Externí odkaz:
https://doaj.org/article/320587b30d454079837bd3319d6310c0
Autor:
Karin E. de Visser, Hannah Garner
Publikováno v:
Nature Reviews Immunology. 20:483-497
Metastatic disease is responsible for approximately 90% of cancer deaths. For successful dissemination and metastasis, cancer cells must evade detection and destruction by the immune system. This process is enabled by factors secreted by the primary
Autor:
Olga S, Blomberg, Lorenzo, Spagnuolo, Hannah, Garner, Leonie, Voorwerk, Olga I, Isaeva, Ewald, van Dyk, Noor, Bakker, Myriam, Chalabi, Chris, Klaver, Maxime, Duijst, Kelly, Kersten, Marieke, Brüggemann, Dorien, Pastoors, Cheei-Sing, Hau, Kim, Vrijland, Elisabeth A M, Raeven, Daphne, Kaldenbach, Kevin, Kos, Inna S, Afonina, Paulien, Kaptein, Louisa, Hoes, Willemijn S M E, Theelen, Paul, Baas, Emile E, Voest, Rudi, Beyaert, Daniela S, Thommen, Lodewyk F A, Wessels, Karin E, de Visser, Marleen, Kok
Publikováno v:
Cancer cell.
Immune checkpoint blockade (ICB) has heralded a new era in cancer therapy. Research into the mechanisms underlying response to ICB has predominantly focused on T cells; however, effective immune responses require tightly regulated crosstalk between i
Autor:
Olga S. Blomberg, Lorenzo Spagnuolo, Hannah Garner, Leonie Voorwerk, Olga I. Isaeva, Ewald van Dyk, Noor Bakker, Myriam Chalabi, Chris Klaver, Maxime Duijst, Kelly Kersten, Marieke Brüggemann, Dorien Pastoors, Cheei-Sing Hau, Kim Vrijland, Elisabeth A.M. Raeven, Daphne Kaldenbach, Kevin Kos, Inna S. Afonina, Paulien Kaptein, Louisa Hoes, Willemijn S.M.E. Theelen, Paul Baas, Emile E. Voest, Rudi Beyaert, Daniela S. Thommen, Lodewyk F.A. Wessels, Karin E. de Visser, Marleen Kok
Publikováno v:
CANCER CELL
Immune checkpoint blockade (ICB) has heralded a new era in cancer therapy. Research into the mechanisms underlying response to ICB has predominantly focused on T cells; however, effective immune responses require tightly regulated crosstalk between i
Autor:
Hannah, Garner, Karin E, de Visser
Publikováno v:
Nature reviews. Immunology. 20(8)
Metastatic disease is responsible for approximately 90% of cancer deaths. For successful dissemination and metastasis, cancer cells must evade detection and destruction by the immune system. This process is enabled by factors secreted by the primary
Autor:
Ana-Maria Lennon-Duménil, Enrique Gutiérrez-Martinez, Stéphanie Hugues, Grégoire Lauvau, Hannah Garner, Jakob Loschko, Emmanuel L. Gautier, Rachel Golub, Jake Y. Henry, Elisa Gomez-Perdiguero, Shinelle Menezes, Frederic Geissmann, M. Paula Longhi, Daisy Melandri, Christian E. Jacome-Galarza, Alain Bessis, Pierre Guermonprez, Thibaut Perchet, Giorgio Anselmi, Juan Dubrot, Sergio A. Quezada, Rajen Patel, Michel C. Nussenzweig
Publikováno v:
Immunity
Immunity, Elsevier, 2016, 45 (6), pp.1205-1218. ⟨10.1016/j.immuni.2016.12.001⟩
Immunity, Vol. 45, No 6 (2016) pp. 1205-1218
Immunity, 2016, 45 (6), pp.1205-1218. ⟨10.1016/j.immuni.2016.12.001⟩
Menezes, S, Melandri, D, Anselmi, G, Perchet, T, Loschko, J, Dubrot, J, Patel, R, Gautier, E L, Hugues, S, Longhi, M P, Henry, J Y, Quezada, S A, Lauvau, G, Lennon-Duménil, A M, Gutiérrez-Martínez, E, Bessis, A, Gomez-Perdiguero, E, Jacome-Galarza, C E, Garner, H, Geissmann, F, Golub, R, Nussenzweig, M C & Guermonprez, P 2016, ' The Heterogeneity of Ly6C hi Monocytes Controls Their Differentiation into iNOS + Macrophages or Monocyte-Derived Dendritic Cells ', Immunity, vol. 45, no. 6, pp. 1205-1218 . https://doi.org/10.1016/j.immuni.2016.12.001
Immunity, Elsevier, 2016, 45 (6), pp.1205-1218. ⟨10.1016/j.immuni.2016.12.001⟩
Immunity, Vol. 45, No 6 (2016) pp. 1205-1218
Immunity, 2016, 45 (6), pp.1205-1218. ⟨10.1016/j.immuni.2016.12.001⟩
Menezes, S, Melandri, D, Anselmi, G, Perchet, T, Loschko, J, Dubrot, J, Patel, R, Gautier, E L, Hugues, S, Longhi, M P, Henry, J Y, Quezada, S A, Lauvau, G, Lennon-Duménil, A M, Gutiérrez-Martínez, E, Bessis, A, Gomez-Perdiguero, E, Jacome-Galarza, C E, Garner, H, Geissmann, F, Golub, R, Nussenzweig, M C & Guermonprez, P 2016, ' The Heterogeneity of Ly6C hi Monocytes Controls Their Differentiation into iNOS + Macrophages or Monocyte-Derived Dendritic Cells ', Immunity, vol. 45, no. 6, pp. 1205-1218 . https://doi.org/10.1016/j.immuni.2016.12.001
Summary Inflammation triggers the differentiation of Ly6Chi monocytes into microbicidal macrophages or monocyte-derived dendritic cells (moDCs). Yet, it is unclear whether environmental inflammatory cues control the polarization of monocytes toward e
Autor:
Leonie Voorwerk, Olga S. Blomberg, L. Spagnuolo, M.S. van der Heijden, M. Duijst, Emile E. Voest, E. van Dyk, J. van Dorp, K.E. De Visser, Olga I. Isaeva, Marleen Kok, Myriam Chalabi, Hannah Garner, Lodewyk F. A. Wessels, Kelly Kersten, C. Klaver, Noor A. M. Bakker, L.R. Hoes, Willemijn S. M. E. Theelen
Publikováno v:
Annals of Oncology. 31:S1142